Cytek Biosciences, Inc.
CTKB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001831915
No open-market purchases or sales by Cytek Biosciences, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $361.0M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Cytek Biosciences, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 153 | 1 | 161 | +9 |
| Shares | 77.3M | 317.3K | 77.5M | +578.7K (+0.8%) |
| Value | $501.4M | $2.06M | $310.8M | −$188.5M (−37.7%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (30)
Institutions that held Cytek Biosciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (21)
Institutions that held Cytek Biosciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Wellington Management Group LLP | 1,517,214 | $9.85M |
| Raymond James Financial Inc | 117,870 | $765.0K |
| Alyeska Investment Group, L.P. | 100,000 | $649.0K |
| Weiss Asset Management LP | 82,523 | $535.6K |
| ExodusPoint Capital Management, LP | 77,536 | $503.0K |
| Segall Bryant & Hamill, LLC | 56,501 | $366.7K |
| Dark Forest Capital Management LP | 49,847 | $323.5K |
| Versor Investments LP | 47,000 | $305.0K |
| Cornerstone Investment Partners, LLC | 31,411 | $203.9K |
| Pacer Advisors, Inc. | 30,155 | $195.7K |
| Bayesian Capital Management, LP | 22,900 | $148.6K |
| Keebeck Alpha, LP | 19,601 | $127.2K |
| Bailard, Inc. | 18,900 | $122.7K |
| Canada Pension Plan Investment Board | 14,300 | $92.8K |
| Mariner, LLC | 13,098 | $85.0K |
| R Squared Ltd | 280 | $1.82K |
| SRS Capital Advisors, Inc. | 187 | $1.21K |
| Lindbrook Capital, LLC | 94 | $610 |
| Allworth Financial LP | 98 | $566 |
| Parkside Financial Bank & Trust | 39 | $254 |
| Capital Advisors, Ltd. LLC | 39 | $0 |
Not filed for Q1 2025 yet (1)
Institutions that held Cytek Biosciences, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 317,301 | $2.06M |